Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Total Current Assets
All assets expected to be converted to cash or used up within one year.
Total Current Assets history
Currency unavailable · from the balance sheet
No Total Current Assets data reported for this period type.
Total Current Assets vs competitors
How APMD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $608.67M USD | +6.2% | +3.3% | 65.7% | |
| Mar 2026 | €40.72M EUR | -45.9% | -15.2% | 41.6% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | -19.8% | -6.0% | 53.6% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.